- Home
- HUT vs IRON Comparison
HUT vs IRON Comparison
Compare HUT & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUT
- IRON
- Stock Information
- Founded
- HUT 2011
- IRON 2017
- Country
- HUT United States
- IRON United States
- Employees
- HUT N/A
- IRON N/A
- Industry
- HUT Finance: Consumer Services
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- HUT Finance
- IRON Health Care
- Exchange
- HUT Nasdaq
- IRON Nasdaq
- Market Cap
- HUT 1.6B
- IRON 1.4B
- IPO Year
- HUT N/A
- IRON N/A
- Fundamental
- Price
- HUT $16.70
- IRON $51.61
- Analyst Decision
- HUT Strong Buy
- IRON Strong Buy
- Analyst Count
- HUT 14
- IRON 10
- Target Price
- HUT $26.64
- IRON $93.40
- AVG Volume (30 Days)
- HUT 6.3M
- IRON 372.4K
- Earning Date
- HUT 08-12-2025
- IRON 08-07-2025
- Dividend Yield
- HUT N/A
- IRON N/A
- EPS Growth
- HUT N/A
- IRON N/A
- EPS
- HUT N/A
- IRON N/A
- Revenue
- HUT $132,459,000.00
- IRON N/A
- Revenue This Year
- HUT $74.79
- IRON N/A
- Revenue Next Year
- HUT $116.78
- IRON N/A
- P/E Ratio
- HUT N/A
- IRON N/A
- Revenue Growth
- HUT 0.24
- IRON N/A
- 52 Week Low
- HUT $8.73
- IRON $30.82
- 52 Week High
- HUT $31.95
- IRON $68.73
- Technical
- Relative Strength Index (RSI)
- HUT 50.50
- IRON 56.99
- Support Level
- HUT $17.35
- IRON $48.87
- Resistance Level
- HUT $18.60
- IRON $54.13
- Average True Range (ATR)
- HUT 1.07
- IRON 2.31
- MACD
- HUT -0.19
- IRON 0.07
- Stochastic Oscillator
- HUT 39.39
- IRON 67.64
About HUT Hut 8 Corp.
Hut 8 Corp is an energy infrastructure operator and Bitcoin miner with self-mining, hosting, managed services, and traditional data center operations across North America. The company has four reportable business segments: Power, Digital Infrastructure, Compute, and Other. It derives maximum revenue from the Compute segment which consists of Bitcoin Mining, GPU-as-a-Service, and Data Center Cloud operations. Its geographical segments include the United States and Canada, of which it generates the majority of revenue from the United States.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.